Aaron B. Koenig

12.2k total citations · 3 hit papers
15 papers, 8.8k citations indexed

About

Aaron B. Koenig is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Aaron B. Koenig has authored 15 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Hepatology and 4 papers in Molecular Biology. Recurrent topics in Aaron B. Koenig's work include Liver Disease Diagnosis and Treatment (9 papers), Alcohol Consumption and Health Effects (4 papers) and Liver Disease and Transplantation (3 papers). Aaron B. Koenig is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Alcohol Consumption and Health Effects (4 papers) and Liver Disease and Transplantation (3 papers). Aaron B. Koenig collaborates with scholars based in United States and Germany. Aaron B. Koenig's co-authors include Zobair M. Younossi, Linda Henry, Yousef Fazel, Dinan Abdelatif, Mehmet Sayıner, Zachary Goodman, Pegah Golabi, Munkhzul Otgonsuren, Sean Felix and Rebecca Cable and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Molecular Biology of the Cell.

In The Last Decade

Aaron B. Koenig

15 papers receiving 8.7k citations

Hit Papers

Global epidemiology of nonalcoholic fatty liver disease—M... 2015 2026 2018 2022 2015 2015 2016 2.5k 5.0k 7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
    2015 7.7k citations Zobair M. Younossi, Aaron B. Koenig et al. Hepatology profile →
  2. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World
    2015 411 citations Mehmet Sayıner, Aaron B. Koenig et al. Clinics in Liver Disease profile →
  3. Epidemiology and natural history of non-alcoholic fatty liver disease
    2016 334 citations Yousef Fazel, Aaron B. Koenig et al. Metabolism profile →

Peers

Aaron B. Koenig
Yousef Fazel United States
Mohammed Eslam Australia
Dinan Abdelatif United States
Sven Francque Belgium
Yao‐Chang Liu United States
Mazen Noureddin United States
Naim Alkhouri United States
Ester Vanni Italy
Pegah Golabi United States
Helena Cortez‐Pinto Portugal
Yousef Fazel United States
Aaron B. Koenig
Citations per year, relative to Aaron B. Koenig Aaron B. Koenig (= 1×) peers Yousef Fazel

Countries citing papers authored by Aaron B. Koenig

Since Specialization
Citations

This map shows the geographic impact of Aaron B. Koenig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron B. Koenig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron B. Koenig more than expected).

Fields of papers citing papers by Aaron B. Koenig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron B. Koenig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron B. Koenig. The network helps show where Aaron B. Koenig may publish in the future.

Co-authorship network of co-authors of Aaron B. Koenig

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron B. Koenig. A scholar is included among the top collaborators of Aaron B. Koenig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron B. Koenig. Aaron B. Koenig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Koenig, Aaron B., et al.. (2024). Review article: Hepatic steatosis and its associations with acute and chronic liver diseases. Alimentary Pharmacology & Therapeutics. 60(2). 167–200. 8 indexed citations
2.
Ding, Li, Aaron B. Koenig, Pearlly S. Yan, et al.. (2022). AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells. Frontiers in Cell and Developmental Biology. 10. 853652–853652. 15 indexed citations
3.
Koenig, Aaron B., et al.. (2018). A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma. International Journal of Molecular Sciences. 19(3). 851–851. 29 indexed citations
4.
Golabi, Pegah, Munkhzul Otgonsuren, Rebecca Cable, et al.. (2016). Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL). Health and Quality of Life Outcomes. 14(1). 18–18. 115 indexed citations
5.
6.
Mehta, Rohini, et al.. (2016). The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH). BMC Medical Genetics. 17(1). 63–63. 25 indexed citations
7.
Fazel, Yousef, Aaron B. Koenig, Mehmet Sayıner, Zachary Goodman, & Zobair M. Younossi. (2016). Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism. 65(8). 1017–1025. 334 indexed citations breakdown →
8.
Koenig, Aaron B., Maria Stepanova, Sammy Saab, et al.. (2016). Long‐term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the U.S. transplant registry. Alimentary Pharmacology & Therapeutics. 44(3). 271–278. 14 indexed citations
9.
Koenig, Aaron B., et al.. (2016). Vaccination against hepatitis A and B in patients with chronic liver disease and type 2 diabetes: has anything changed?. Liver International. 36(8). 1096–1100. 6 indexed citations
10.
Younossi, Zobair M., et al.. (2015). Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 64(1). 73–84. 7727 indexed citations breakdown →
11.
Zhang, Huaiying, et al.. (2015). Ploidy variation in multinucleate cells changes under stress. Molecular Biology of the Cell. 26(6). 1129–1140. 36 indexed citations
12.
Golabi, Pegah, Mehmet Sayıner, Yousef Fazel, et al.. (2015). Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis. Expert Review of Gastroenterology & Hepatology. 10(1). 63–71. 48 indexed citations
13.
Sayıner, Mehmet, Aaron B. Koenig, Linda Henry, & Zobair M. Younossi. (2015). Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. Clinics in Liver Disease. 20(2). 205–214. 411 indexed citations breakdown →
14.
Jain, Rajat, Conrad F. Piskorz, Robert D. Locke, et al.. (1998). Inhibition of L- and P-selectin by a rationally synthesized novel core 2-like branched structure containing GalNAc-Lewisx and Neu5Ac 2-3Gal 1-3GalNAc sequences. Glycobiology. 8(7). 707–717. 26 indexed citations
15.
Koenig, Aaron B., et al.. (1987). Transepithelial Electric Potential Difference in Newborns Undergoing Phototherapy. Pediatric Research. 21(3). 283–284. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yousef Fazel Breakdown of academic impact, for papers by Mohammed Eslam Breakdown of academic impact, for papers by Dinan Abdelatif Breakdown of academic impact, for papers by Sven Francque Breakdown of academic impact, for papers by Yao‐Chang Liu Breakdown of academic impact, for papers by Mazen Noureddin Breakdown of academic impact, for papers by Naim Alkhouri Breakdown of academic impact, for papers by Ester Vanni Breakdown of academic impact, for papers by Pegah Golabi Breakdown of academic impact, for papers by Helena Cortez‐Pinto
Rankless by CCL
2026